Hiroko Natsume

567 total citations
17 papers, 419 citations indexed

About

Hiroko Natsume is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, Hiroko Natsume has authored 17 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Hiroko Natsume's work include Thyroid Disorders and Treatments (7 papers), Estrogen and related hormone effects (3 papers) and Retinoids in leukemia and cellular processes (3 papers). Hiroko Natsume is often cited by papers focused on Thyroid Disorders and Treatments (7 papers), Estrogen and related hormone effects (3 papers) and Retinoids in leukemia and cellular processes (3 papers). Hiroko Natsume collaborates with scholars based in Japan and United States. Hiroko Natsume's co-authors include Akira Nishiyama, Kazuki Mochizuki, Moon Kyoo Jang, Asim K. Ghosh, Tomohiko Tamura, Keiko Ozato, Anup Dey, Hongjie Yao, Hirotoshi Nakamura and Kozo Nishiyama and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Metabolism.

In The Last Decade

Hiroko Natsume

17 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroko Natsume Japan 8 296 65 64 60 58 17 419
Yoshitaka Kuwahara Japan 10 280 0.9× 57 0.9× 41 0.6× 31 0.5× 25 0.4× 22 437
Hidetaka Niizuma Japan 12 136 0.5× 18 0.3× 68 1.1× 80 1.3× 52 0.9× 34 368
Matthew P. Vasievich United States 9 166 0.6× 28 0.4× 25 0.4× 45 0.8× 30 0.5× 12 407
Mathias Hauri‐Hohl Switzerland 11 134 0.5× 54 0.8× 74 1.2× 68 1.1× 111 1.9× 22 469
Daria Domańska Poland 13 135 0.5× 46 0.7× 68 1.1× 88 1.5× 10 0.2× 18 328
Flávia Roche Moreira Latini Brazil 11 101 0.3× 60 0.9× 41 0.6× 79 1.3× 106 1.8× 34 342
Luisa Ronzoni Italy 13 188 0.6× 27 0.4× 22 0.3× 78 1.3× 71 1.2× 43 455
Pavlos Fanis Cyprus 12 283 1.0× 71 1.1× 22 0.3× 146 2.4× 185 3.2× 36 618
Yifan Mao United States 11 242 0.8× 26 0.4× 46 0.7× 24 0.4× 13 0.2× 39 389
T Fukuda Japan 11 122 0.4× 98 1.5× 43 0.7× 70 1.2× 19 0.3× 16 352

Countries citing papers authored by Hiroko Natsume

Since Specialization
Citations

This map shows the geographic impact of Hiroko Natsume's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Natsume with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Natsume more than expected).

Fields of papers citing papers by Hiroko Natsume

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroko Natsume. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Natsume. The network helps show where Hiroko Natsume may publish in the future.

Co-authorship network of co-authors of Hiroko Natsume

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroko Natsume. A scholar is included among the top collaborators of Hiroko Natsume based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroko Natsume. Hiroko Natsume is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Gurzu, Simona, Ioan Jung, Haruhiko Sugimura, et al.. (2020). Maspin subcellular expression in wild-type and mutant TP53 gastric cancers. World Journal of Gastrointestinal Oncology. 12(7). 741–755. 10 indexed citations
2.
Shinmura, Kazuya, Nobuya Kurabe, Masanori Goto, et al.. (2014). PLK4 overexpression and its effect on centrosome regulation and chromosome stability in human gastric cancer. Molecular Biology Reports. 41(10). 6635–6644. 50 indexed citations
3.
Natsume, Hiroko, Kazuya Shinmura, Tao Hong, et al.. (2012). The CRKL gene encoding an adaptor protein is amplified, overexpressed, and a possible therapeutic target in gastric cancer. Journal of Translational Medicine. 10(1). 97–97. 20 indexed citations
4.
Natsume, Hiroko, et al.. (2009). Survey on Health Insurance Pharmacy Pharmacists Image of Clinical Trials-Comparison with that of Pharmacy Students-. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 35(5). 325–336. 2 indexed citations
5.
Mochizuki, Kazuki, Akira Nishiyama, Moon Kyoo Jang, et al.. (2008). The Bromodomain Protein Brd4 Stimulates G1 Gene Transcription and Promotes Progression to S Phase. Journal of Biological Chemistry. 283(14). 9040–9048. 188 indexed citations
6.
Natsume, Hiroko, Shigekazu Sasaki, Masatoshi Kitagawa, et al.. (2003). β-Catenin/Tcf-1-mediated transactivation of cyclin D1 promoter is negatively regulated by thyroid hormone. Biochemical and Biophysical Research Communications. 309(2). 408–413. 42 indexed citations
7.
Nishiyama, Kozo, Satoshi Baba, Tomoko Yamada, et al.. (2003). Embryonic Lethal Effect of Expressing a Dominant Negative Mutant Human Thyroid Hormone Receptor .ALPHA.1 in Mice. Endocrine Journal. 50(5). 561–570. 1 indexed citations
8.
Nishiyama, Kozo, Hiroko Natsume, Akio Matsushita, et al.. (2001). Malignant Hyperthermia in a Patient with Graves' Disease during Subtotal Thyroidectomy.. Endocrine Journal. 48(2). 227–232. 6 indexed citations
9.
Miura, Katsutoshi, et al.. (2001). Histological Changes of Thyroid Tissues in Patients with Liver Cirrhosis.. Endocrine Journal. 48(5). 535–542. 4 indexed citations
10.
Nishiyama, Kozo, et al.. (2000). Differences between the silencing-related properties of the extreme carboxyl-terminal regions of thyroid hormone receptors alpha 1 and beta 1. Journal of Endocrinology. 167(2). 219–227. 7 indexed citations
11.
Misawa, Hiroko, et al.. (2000). Very strong correlation between dominant negative activities of mutant thyroid hormone receptors and their binding avidity for corepressor SMRT. Journal of Endocrinology. 167(3). 493–503. 17 indexed citations
12.
Nishiyama, Kozo, et al.. (1998). Difference in dominant negative activities between mutant thyroid hormone receptors α1 and β1 with an identical truncation in the extreme carboxyl-terminal tau4 domain. Molecular and Cellular Endocrinology. 138(1-2). 95–104. 5 indexed citations
13.
Mikami, Tomoko, Kozo Nishiyama, Shinichiro Ando, et al.. (1998). Alterations in the enzyme activity and protein contents of protein disulfide isomerase in rat tissues during fasting and refeeding. Metabolism. 47(9). 1083–1088. 6 indexed citations
14.
Nakamura, Hirotoshi, Tomoko Mikami, Hiroko Natsume, et al.. (1997). High Incidence of Positive Autoantibodies against Thyroid Peroxidase and Thyroglobulin in Patients with Sarcoidosis. Clinical Endocrinology. 46(4). 467–472. 43 indexed citations
15.
Ando, Shinichiro, Hirotoshi Nakamura, Shigekazu Sasaki, et al.. (1996). Introducing a point mutation identified in a patient with pituitary resistance to thyroid hormone (Arg 338 to Trp) into other mutant thyroid hormone receptors weakens their dominant negative activities. Journal of Endocrinology. 151(2). 293–300. 10 indexed citations
16.
Nakamura, Hirotoshi, Tomoko Mori, Yoshikazu Suzuki, et al.. (1996). Urinary excretion of pyridinoline and deoxypyridinoline measured by immunoassay in hypothyroidism. Clinical Endocrinology. 44(4). 447–451. 7 indexed citations
17.
Natsume, Hiroko, et al.. (1985). [The effectiveness of a combination of trimethoprim plus rifampicin and local injection of antibiotics into the prostate in chronic bacterial prostatitis].. PubMed. 31(3). 441–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshitaka Kuwahara Breakdown of academic impact, for papers by Hidetaka Niizuma Breakdown of academic impact, for papers by Matthew P. Vasievich Breakdown of academic impact, for papers by Mathias Hauri‐Hohl Breakdown of academic impact, for papers by Daria Domańska Breakdown of academic impact, for papers by Flávia Roche Moreira Latini Breakdown of academic impact, for papers by Luisa Ronzoni Breakdown of academic impact, for papers by Pavlos Fanis Breakdown of academic impact, for papers by Yifan Mao Breakdown of academic impact, for papers by T Fukuda
Rankless by CCL
2026